Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HealthEquity, Inc. - Common Stock (NQ: HQY )

85.08 -1.00 (-1.16%)
Streaming Delayed Price Updated: 11:39 AM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HealthEquity, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
HealthEquity, Inc. Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
Why HEALTHEQUITY INC (NASDAQ:HQY) Is a Standout High-Growth Stock in a Consolidation Phase.
Based on fundamental and technical analysis of NASDAQ:HQY we ask: Why HEALTHEQUITY INC (NASDAQ:HQY) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
HealthEquity, Inc. Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
Expert Outlook: HealthEquity Through The Eyes Of 8 Analysts
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
HealthEquity, Inc. Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
Rosen Law Firm Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation – HQY
From The Rosen Law Firm, P.A.
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
HealthEquity Earns Stock Upgrade Despite Fraud Concerns
HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns. 
Via Benzinga
Topics Fraud
Exposures Legal
Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside
Avalo Therapeutics' AVTX-009 is advancing in hidradenitis suppurativa, with Phase 2 data expected in 2026. Stifel initiates coverage with a $36 price target. 
Via Benzinga
This Cloudflare Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
$1000 Invested In HealthEquity 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Why HealthEquity Stock Was Sliding This Week
Via The Motley Fool
HealthEquity Stock Sees Biggest Drop In Over 3 Years On Disappointing Outlook — Retail Doesn't Feel It's All Doom And Gloom
CFO James Lucania said on the earnings call that fraud prevention efforts are ongoing, and service expenses are expected to remain elevated through the first half of fiscal 2026. 
Via Stocktwits
Topics Earnings Fraud
Exposures Financial Legal
4 Analysts Assess HealthEquity: What You Need To Know
Via Benzinga
HealthEquity's Long-Term Growth Intact Despite Short-Term Margin Pressures, Analyst Says
HealthEquity reported 19% revenue growth but missed Q4 EPS estimates. Analysts see earnings improving as cybersecurity costs ease and HSA growth continues. 
Via Benzinga
Dow, Nasdaq Rally Ahead Of Interest Rate Decision
Stocks are rallying ahead of the Federal Reserve's interest rate decision, due out later this afternoon. 
Via Talk Markets
Topics Economy Stocks Stocks / Equities
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Wednesday's session: gap up and gap down stocks
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Discover the top movers in Wednesday's pre-market session.
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article. 
Via Chartmill
Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open Higher Ahead Of FOMC Decision: 'Tariffs Remain The Dominant Market Force' Amid Rising Economic Uncertainty, Says Expert
U.S. stock futures advanced on Wednesday ahead of the Federal Open Market Committee's decision on the interest rates. 
Via Benzinga
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.